XML 63 R9.htm IDEA: XBRL DOCUMENT
v3.19.3

Revenue Recognition | 9 Months Ended
--- | ---
Sep. 30, 2019
Revenue Recognition [Abstract] |
Revenue Recognition | REVENUE RECOGNITION Our policies for recognizing sales have not changed from those described in our Annual Report on Form 10-K for 2018. We disaggregate our net sales by product line and geography for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.
Net Sales by Product Line |  |  |  |  |
| Three Months |  | Nine Months
| 2019 | 2018 |  | 2019 | 2018
Orthopaedics: |  |  |  |  |
Knees | $ | 426 |  | $ | 395 |  |  | $ | 1,305 |  | $ | 1,236 |
Hips | 332 |  | 316 |  |  | 1,011 |  | 983 |
Trauma and Extremities | 407 |  | 376 |  |  | 1,197 |  | 1,152 |
Other | 97 |  | 84 |  |  | 272 |  | 244 |
| $ | 1,262 |  | $ | 1,171 |  |  | $ | 3,785 |  | $ | 3,615 |
MedSurg: |  |  |  |  |
Instruments | $ | 476 |  | $ | 442 |  |  | $ | 1,474 |  | $ | 1,292 |
Endoscopy | 474 |  | 443 |  |  | 1,424 |  | 1,335 |
Medical | 554 |  | 492 |  |  | 1,627 |  | 1,508 |
Sustainability | 72 |  | 66 |  |  | 212 |  | 190 |
| $ | 1,576 |  | $ | 1,443 |  |  | $ | 4,737 |  | $ | 4,325 |
Neurotechnology and Spine: |  |  |  |  |
Neurotechnology | $ | 488 |  | $ | 435 |  |  | $ | 1,436 |  | $ | 1,282 |
Spine | 261 |  | 193 |  |  | 795 |  | 583 |
| $ | 749 |  | $ | 628 |  |  | $ | 2,231 |  | $ | 1,865 |
Total | $ | 3,587 |  | $ | 3,242 |  |  | $ | 10,753 |  | $ | 9,805 |
Net Sales by Geography |  |  |  |  |
| Three Months 2019 |  | Three Months 2018
| United States | International |  | United States | International
Orthopaedics: |  |  |  |  |
Knees | $ | 318 |  | $ | 108 |  |  | $ | 291 |  | $ | 104 |
Hips | 211 |  | 121 |  |  | 198 |  | 118 |
Trauma and Extremities | 262 |  | 145 |  |  | 242 |  | 134 |
Other | 81 |  | 16 |  |  | 67 |  | 17 |
| $ | 872 |  | $ | 390 |  |  | $ | 798 |  | $ | 373 |
MedSurg: |  |  |  |  |
Instruments | $ | 373 |  | $ | 103 |  |  | $ | 352 |  | $ | 90 |
Endoscopy | 377 |  | 97 |  |  | 346 |  | 97 |
Medical | 442 |  | 112 |  |  | 393 |  | 99 |
Sustainability | 71 |  | 1 |  |  | 66 |  | — |
| $ | 1,263 |  | $ | 313 |  |  | $ | 1,157 |  | $ | 286 |
Neurotechnology and Spine: |  |  |  |  |
Neurotechnology | $ | 314 |  | $ | 174 |  |  | $ | 284 |  | $ | 150 |
Spine | 195 |  | 66 |  |  | 142 |  | 52 |
| $ | 509 |  | $ | 240 |  |  | $ | 426 |  | $ | 202 |
Total | $ | 2,644 |  | $ | 943 |  |  | $ | 2,381 |  | $ | 861 |
Net Sales by Geography |  |  |  |  |
| Nine Months 2019 |  | Nine Months 2018
| United States | International |  | United States | International
Orthopaedics: |  |  |  |  |
Knees | $ | 962 |  | $ | 343 |  |  | $ | 896 |  | $ | 340 |
Hips | 643 |  | 368 |  |  | 610 |  | 373 |
Trauma and Extremities | 768 |  | 429 |  |  | 729 |  | 423 |
Other | 223 |  | 49 |  |  | 198 |  | 46 |
| $ | 2,596 |  | $ | 1,189 |  |  | $ | 2,433 |  | $ | 1,182 |
MedSurg: |  |  |  |  |
Instruments | $ | 1,168 |  | $ | 306 |  |  | $ | 1,007 |  | $ | 285 |
Endoscopy | 1,136 |  | 288 |  |  | 1,049 |  | 286 |
Medical | 1,288 |  | 339 |  |  | 1,158 |  | 350 |
Sustainability | 210 |  | 2 |  |  | 189 |  | 1 |
| $ | 3,802 |  | $ | 935 |  |  | $ | 3,403 |  | $ | 922 |
Neurotechnology and Spine: |  |  |  |  |
Neurotechnology | $ | 922 |  | $ | 514 |  |  | $ | 820 |  | $ | 462 |
Spine | 598 |  | 197 |  |  | 424 |  | 159 |
| $ | 1,520 |  | $ | 711 |  |  | $ | 1,244 |  | $ | 621 |
Total | $ | 7,918 |  | $ | 2,835 |  |  | $ | 7,080 |  | $ | 2,725 |
Contract Assets and Liabilities On September 30, 2019 there were no contract assets recorded on our Consolidated Balance Sheets. Our contract liabilities arise as a result of consideration received from customers at inception of contracts for certain businesses or where the timing of billing for services precedes satisfaction of our performance obligations. We generally satisfy performance obligations within one year from the contract inception date. Our contract liabilities were $319 and $327 on September 30, 2019 and December 31, 2018.

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of accounting policy for recognizing unearned income or deferred revenue related to transactions involving the sale of a product or performance of services. + References Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790 + Details
Name: | us-gaap_RevenueRecognitionDeferredRevenue
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration